Bone Remodeling in Children with Acute Lymphoblastic Leukemia: A Two-Year Prospective Longitudinal Study

Area of Science:

• Pediatric Oncology
• Bone Biology
• Hematology

Background:

• Childhood leukemia survivors face long-term complications, including potential bone health issues.
• Limited data exists on bone remodeling dynamics in pediatric acute lymphoblastic leukemia (ALL).

Purpose of the Study:

• To investigate bone remodeling and turnover markers in children with ALL.
• To clarify the influence of leukemia and chemotherapy on bone health during treatment.

Main Methods:

• Prospective longitudinal study of 22 children with ALL (<18 years) over 2 years.
• Assessed bone turnover markers (OPG, RANKL, OC, CTX, bALP, TRACP5b, P1NP, DKK-1, sclerostin) at 5 time points.
• Compared patient data to a healthy control group using principal component analysis (PCA).

Main Results:

• ALL children showed lower levels of CTX, OC, P1NP, bALP, DKK-1, and sclerostin compared to controls.
• Elevated RANKL and OPG levels were observed in ALL patients.
• Significant increases in CTX, OC, P1NP, TRACP5b, and bALP occurred during treatment, especially post-induction.

Conclusions:

• Leukemia onset significantly slows bone remodeling in children with ALL.
• Bone turnover markers show dynamic changes throughout leukemia treatment.